The U.S. Patent and Trademark Office (USPTO) recently awarded Nextremity Solutions, Inc. with seven additional patents. The patents are a mix of design and utility patents related to medical devices specific to the treatment of foot and ankle deformities.

Director of Product Development, Ryan Schlotterback, stated, “We are pleased with the Nextremity Intellectual Property that was issued recently and feel that it is indicative of the hard work and talent of our surgeon partners and product development staff.  We are proud of our unique product portfolio and are committed to developing innovative solutions that continue to advance the standard of care in the foot and ankle market.”

Some of the patents relate specifically to current implants that Nextremity Solutions markets, including the Nextra® Hammertoe Correction System, as well as the MSPTM Metatarsal Shortening System. Additional products in the company’s product pipeline are also utilizing the technology developed in the issued patents.

“As surgeons, we start with a concept. When these visions become products and procedures that allow surgeons to offer their patients a unique and better solution, we as doctors have achieved something special,” said Nextremity Solutions founder Lon S. Weiner, MD.

Co-founder Stuart D. Katchis, MD noted, “All of our work at Nextremity Solutions has been focused on designing unique products that make complex foot and ankle surgical procedures more consistently successful. The issuance of these patents and the success we have seen clinically, confirm the value of our products to surgeons and patients alike.”

“The issuance of these patents by the USPTO is definitely exciting for us as a company. It truly speaks to the fact that we, as a pure-play foot and ankle company, are committed to working closely with our foot and ankle surgeon partners to develop innovative solutions in the foot and ankle market,” commented Rod K. Mayer, president of Nextremity Solutions.